2 results match your criteria: "Western University Lawson Health Research Institute[Affiliation]"

Swift Intrahepatic Accumulation of Granulocytic Myeloid-Derived Suppressor Cells in a Humanized Mouse Model of Toxic Shock Syndrome.

J Infect Dis

June 2016

Department of Microbiology and Immunology Centre for Human Immunology Division of Clinical Immunology and Allergy, Department of Medicine, Western University Lawson Health Research Institute, London, Canada.

Toxic shock syndrome (TSS) and other superantigen-mediated illnesses are associated with 'systemic' immunosuppression that jeopardizes the host's ability to fight pathogens. Here, we define a novel mechanism of 'local' immunosuppression that may benefit the host. Systemic exposure to staphylococcal enterotoxin B (SEB) rapidly and selectively recruited CD11b(+)Gr-1(high)Ly-6C(+) granulocytic myeloid-derived suppressor cells (MDSCs) to the liver of HLA-DR4 transgenic mice.

View Article and Find Full Text PDF

Targeted siRNA silencing of indoleamine 2, 3-dioxygenase in antigen-presenting cells using mannose-conjugated liposomes: a novel strategy for treatment of melanoma.

J Immunother

October 2014

*Departments of Pathology, Surgery, Oncology, Microbiology and Immunology, Physiology and Pharmacology, Western University ‡Lawson Health Research Institute †London Regional Cancer Program, London, ON, Canada §Jiangxi Academy of Medical Sciences, Institute of Immunomodulation and Immunotherapy of Nanchang University, Nanchang, China.

Indoleamine 2, 3-dioxygenase (IDO) expression in dendritic cells (DCs) leads to the inhibition of T-cell activation, induction of T-cell apoptosis, and promotion of T-cell differentiation into regulatory T cells. All of these could promote tumor escapement of the host's immune surveillance system. We hypothesized that DC-targeted gene silencing of IDO would enhance antitumor immunity and thus restrain tumor growth.

View Article and Find Full Text PDF